Literature DB >> 8275058

The effect of cytokines on bactericidal activity of murine neutrophils.

P A Kenny1, P J McDonald, J J Finlay-Jones.   

Abstract

A range of recombinant cytokines have now been shown to modify aspects of the phenotype and function of human and murine neutrophils. However, few reports describe modification of the bactericidal activity of neutrophils. We therefore examined the recombinant murine cytokines tumor necrosis factor-alpha (TNF-alpha, 10-1000 ng ml-1) and granulocyte macrophage-colony stimulating factor (GM-CSF, 10-1000 U ml-1) for their ability to increase the bacterial killing capacity of murine neutrophils. Neutrophils from either bone marrow (fresh or cultured), or peritoneal exudates, or abscesses, were pre-incubated with either cytokine for 30-60 min and the killing of Proteus mirabilis, Escherichia coli, or Bacteroides fragilis was examined in the presence or absence of serum over a 90 min period. Only for one combination was a small but significantly enhanced level of bacterial killing observed, the phagocytic killing of P. mirabilis by peritoneal exudate neutrophils in the presence of GM-CSF and serum. With this exception there was no enhancement of bacterial killing for the range of combinations of neutrophils and bacterial species tested. In contrast, at the concentrations tested for effect on bactericidal activity, TNF-alpha and GM-CSF were able to significantly upregulate CR3 (but not Fc gamma RII) expression on mouse neutrophils. These results indicate that upregulation of CR3 as an index of neutrophil activation does not necessarily correlate with increased bactericidal activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8275058     DOI: 10.1111/j.1574-695X.1993.tb00408.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  1 in total

Review 1.  Regulation of mast cell-mediated innate immunity during early response to bacterial infection.

Authors:  Ravi Malaviya; Amara Georges
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.